Reinventing healthcare one patient at a time

Press Release

Ellis Medicine Offers the World’s Smallest Pacemaker

Wednesday, March 28, 2018

Miniaturized Heart Device Provides Patients  with the Most Advanced Pacing Technology Available

 

SCHENECTADY, N.Y. — Ellis Medicine today announced that it is one of the first hospitals in New York to offer the world’s smallest pacemaker for patients with bradycardia. The Micra® Transcatheter Pacing System (TPS) is a new type of heart device, approved for Medicare reimbursement, that provides patients with the most advanced pacing technology at one-tenth the size of a traditional pacemaker. The first procedure at Ellis was performed by Dr. Steven F. Giovannone earlier this month.

 

Bradycardia is a condition characterized by a slow or irregular heart rhythm, usually fewer than 60 beats per minute. At this rate, the heart is unable to pump enough oxygen-rich blood to the body during normal activity or exercise, causing dizziness, fatigue, shortness of breath or fainting spells. Pacemakers are the most common way to treat bradycardia to help restore the heart's normal rhythm and relieve symptoms by sending electrical impulses to the heart to increase the heart rate.

 

Comparable in size to a large vitamin, physicians at Ellis Medicine have elected to use Medtronic’s Micra TPS because unlike traditional pacemakers, the device does not require cardiac wires (leads) or a surgical “pocket” under the skin to deliver a pacing therapy. Instead, the device is small enough to be delivered through a catheter and implanted directly into the heart with small tines, providing a safe alternative to conventional pacemakers without the complications associated with leads – all while being cosmetically invisible. The Micra TPS is also designed to automatically adjust pacing therapy based on a patient’s activity levels.

 

"This is a new, exciting technology that offers patients an invisible and safe alternative to conventional pacemakers. It’s innovative and offers patients a minimally invasive option,” said Dr. Giovannone. “It’s another sign that we continue to offer the latest treatment options for our patients as part of a commitment to quality care and innovative care.”

 

The Micra TPS also incorporates a retrieval feature to enable retrieval of the device when possible; however, the device is designed to be left in the body.  For patients who need more than one heart device, the miniaturized Micra TPS was designed with a unique feature that enables it to be permanently turned off so it can remain in the body and a new device can be implanted without risk of electrical interaction.

 

The Micra TPS is the first and only transcatheter pacing system to be approved for both 1.5 and 3 Tesla (T) full-body magnetic resonance imaging (MRI) scans and is designed to allow patients to be followed by their physicians and send data remotely via the Medtronic CareLink® Network.

 

The Micra TPS was approved by the U.S. Food and Drug Administration in April 2016, and has been granted Medicare reimbursement, allowing broad patient access to the novel pacing technology.

 

Ellis Medicine | Newsroom

Ellis Medicine Media Inquiries

Media inquiries should be directed to the Communications Department at Ellis Medicine. The Communications Department is open and staffed Monday through Friday, from 9:00 am until 5:00 pm. The department can be reached by phone at 518.232.9288. If you leave a message your call will typically be returned within 24 hours.

All official communications regarding Ellis Medicine are arranged through the Communications Department. We look forward to working with members of the public and media organizations to provide accurate, up-to-date information about Ellis Medicine.

Contact:

Communications
Ellis Medicine
1101 Nott Street
Schenectady, NY 12308
518.232.9288